PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion
Primary Purpose
Ovarian Cancer
Status
Withdrawn
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
immunohistochemical, methylation, gene transfection
Sponsored by

About this trial
This is an interventional diagnostic trial for Ovarian Cancer focused on measuring Ovarian endometrioid carcinoma, invasion, IGFBP-3, transfection, signal transduction, PTEN, methylation
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of ovarian endometrioid carcinoma Exclusion Criteria: other types of ovarian epithelial carcinoma
Sites / Locations
- National Taiwan University Hospital
Outcomes
Primary Outcome Measures
migration
invasion
metastasis
Secondary Outcome Measures
Immunohistochemical staining
methylation
signal tranduction
Full Information
NCT ID
NCT00173407
First Posted
September 12, 2005
Last Updated
December 26, 2012
Sponsor
National Taiwan University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT00173407
Brief Title
PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion
Official Title
Correlation of PTEN and IGFBP-3 in the Invasion of Ovarian Endometrioid Carcinoma
Study Type
Interventional
2. Study Status
Record Verification Date
December 2012
Overall Recruitment Status
Withdrawn
Study Start Date
January 2006 (undefined)
Primary Completion Date
October 2012 (Actual)
Study Completion Date
October 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Taiwan University Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
We have identified insulin-like growth factor binding protein (IGFBP)-3 as an invasion suppressor gene in ovarian endometrioid carcinoma, and showed association with lower cancer migration, invasion and metastasis. Recently, a novel model of ovarian EC formation from endometriosis was reported, and PTEN was found to be a major protein involved. Inactivation of PTEN has been reported in some ovarian EC tumors and methylation was suggested as one of the major epigenetic changes. This tumorigenesis model has lots of similarity to our established invasion model. Therefore, we plan to study the important of PTEN expression in ovarian EC and if inactivation of PTEN and IFGBP-3 is through methylation. Furthermore, by studying the signal transduction pathways using PTEN and IGFBP-3 transfection, we plan to study the mutual interaction between PTEN and IGFBP-3 on the suppression of tumor invasion in ovarian EC.
Detailed Description
We have successfully established an ovarian cancer cell line (OVTW-59), which was derived from an ovarian endometrioid carcinoma (EC), and have also established an ovarian EC invasion model. By using cDNA microarray and quantitative reverse-transcriptase polymerase chain reaction, we identified insulin-like growth factor binding protein (IGFBP)-3 as an invasion suppressor gene, which were associated with lower cancer migration, invasion and metastasis. Clinically, lower IGFBP-3 was found associated with significantly higher tumor grade, advanced stage and poor survival in patients with EC tumors. Furthermore, we have proved IGFBP-3 expression correlated with lower Erk activation, but with no effect on the activation of Akt. All these two signal transduction proteins have crucial roles in cancer invasion. Recently, a novel model of ovarian EC formation from endometriosis was reported, and PTEN was found to be a major protein involved. Inactivation of PTEN has been reported in some ovarian EC tumors and methylation was suggested as one of the major epigenetic changes. This tumorigenesis model has lots of similarity to our established invasion model. Therefore, we plan to study the important of PTEN expression in ovarian EC and if inactivation of PTEN and IFGBP-3 is through methylation. Furthermore, by studying the signal transduction pathways using PTEN and IGFBP-3 transfection, we plan to study the mutual interaction between PTEN and IGFBP-3 on the suppression of tumor invasion in ovarian EC.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ovarian Cancer
Keywords
Ovarian endometrioid carcinoma, invasion, IGFBP-3, transfection, signal transduction, PTEN, methylation
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
immunohistochemical, methylation, gene transfection
Primary Outcome Measure Information:
Title
migration
Title
invasion
Title
metastasis
Secondary Outcome Measure Information:
Title
Immunohistochemical staining
Title
methylation
Title
signal tranduction
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of ovarian endometrioid carcinoma
Exclusion Criteria:
other types of ovarian epithelial carcinoma
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Torng Pao-Ling, MD, PhD
Organizational Affiliation
Department of Obstetric and Gynecology, National Taiwan University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
National Taiwan University Hospital
City
Taipei
ZIP/Postal Code
10020
Country
Taiwan
12. IPD Sharing Statement
Learn more about this trial
PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion
We'll reach out to this number within 24 hrs